Derivatives of azaspiro compounds for the treatment of pain

Details Derivatives of azaspiro compounds for the treatment of pain Derivatives of azaspiro compounds for the treatment of pain

2007-10-16

2007-10-16

Anderson, Rebecca (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S376000, C514S392000

Reexamination Certificate

active

10935794

ABSTRACT:
This invention relates to azaspiro compounds and their use as medications especially for the treatment of chronic, chronic-phlogistic and/or neuropathic pain. Compounds that lend themselves particularly well to the production of analgesics include 1,3-diazaspiro[4.5]decane-2,4-dion and 1,3-diazaspiro[4.5]decane-2,4-dithion.

REFERENCES:
patent: 2716648 (1955-08-01), Jules et al.
patent: 2732380 (1956-01-01), Reppe et al.
patent: 2866734 (1958-12-01), Shapiro et al.
patent: 3629276 (1971-12-01), Harnden
patent: 4105774 (1978-08-01), Driscoll et al.
patent: 5132451 (1992-07-01), Jennings et al.
patent: 5319135 (1994-06-01), Jennings et al.
patent: 5393750 (1995-02-01), James et al.
patent: 5534520 (1996-07-01), Fisher et al.
patent: 5852029 (1998-12-01), Fisher et al.
patent: 5925672 (1999-07-01), Piomelli et al.
patent: 5948807 (1999-09-01), Efange et al.
patent: 0 017 379 (1980-10-01), None
patent: 0 021 704 (1981-01-01), None
patent: 0 028 485 (1981-05-01), None
patent: 0 008 229 (1982-02-01), None
patent: 0 116 347 (1984-08-01), None
patent: 0 249 328 (1987-12-01), None
patent: 0 252 713 (1988-01-01), None
patent: 0 269 355 (1988-06-01), None
patent: 0 306 251 (1989-03-01), None
patent: 0 409 617 (1991-01-01), None
patent: 0 711 292 (1996-05-01), None
patent: 0 894 497 (1999-02-01), None
patent: 967 718 (1964-08-01), None
patent: 995864 (1965-06-01), None
patent: 1015026 (1965-12-01), None
patent: WO-95/03303 (1995-02-01), None
patent: WO-95/18112 (1995-07-01), None
patent: WO-99/25683 (1999-05-01), None
patent: WO-99/45975 (1999-09-01), None
patent: WO-99/61424 (1999-12-01), None
Hamad et al., “Synthesis and biological activity of 2-thiono-[1H]-5-Spirocyclohexylimidazo[4,3-b] quinazolone and 8-azaquinazolone derivatives,” Boll. Chim. Farmac Annoc, 140(4), pp. 233-237 (2001).
Naydenova et al., II Farmaco, 57:189-194 (2002).
Sarges et al., J. Med. Chem., 31;230-243 (1988).
Hamad et al., Boll. Chim. Farmac., 140(4):233-237 (2001).
Robbe et al., Eur. J. Med. Chem.—Chim. Ther., 17(3):235-243 (1982).
Ismail et al., Egypt. J. Pharm. Sci., 40(1):79-82 (1999).
Hamad et al., Boll. Chim. Farmac.—Anno, 140(4):233-237 (2001).
Robbe et al., Eur. J. Med. Chem—Chim. Ther., 17(3):235-243 (1982).
Courtoison et al., II Farmaco—Ed. Sc., 43(2):153-160 (1987).
Sarges et al., J. Med. Chem., 31:230-243 (1988).
Scholl et al., Structural Chemistry, 10(5):355-366 (1999).
Oldfield et al., Cycloalkanespiro-5′-Hydantoins, “The Chemistry and Pharmacology of a Series of Cycloalkanespiro-5′-hydantoins”, vol. 8, pp. 239-249 (1965).
Rice et al., J. Med. Chem, 6:388-405 (1963).
Grogan et al., J. Med. Chem. 8:62-73 (1965).
Lespagnol et al., Annales Pharmaceutiques Francaises, 10:15-36 (1951).
Ulbricht, Pharmazie, 42(9):598-601 (1987).
Harnden et al., J. Med. Chem., 13(2):305-308 (1970).
Newman et al., J. Am. Ch. Soc., 73:4199-4204 (1951).
Granger et al., Trav. Soc. Pharm. Montpellier, 24:244 (1964).
Regnier et al., Chimie Therapeutique, 3:174-184 (1969).
Badger et al., “Antiarthritic and Suppressor Cell Inducing Activity of Azaspiranes: Structure-Function Relationships of a Novel Class of Immunomodulatory Agents”, J. Med. Chem., Am. Chem. Soc., vol. 33, No. 11, Nov. 1, 1990, pp. 2963-2970.
Luhndahl et al., “Synthesis and Antiviral Activities of Adamantane Spiro Compounds. 1. Adamantane and Analogous Spiro-3′-Pyrrolidines”, J. Med. Chem., Am. Chem. Soc., vol. 15, No. 2, May 1, 1971, pp. 129-131.
Grogan et al., “Spiranes.IV.Alkyl,Cycloalkyl,Alkenyl,Aryl, Arylalkyl, and Hydrazono Azaspirane Derivatives”, J. Med. Chem., Am. Chem. Soc., vol. 7, Aug. 2, 1963, pp. 78-87.
Panouse et al., “Immunomodulator structure-activity relationships:contribution of molesular modeling”, accesion No. 134:110100 XP002248548 & Annales Pharmcaeutiques Fransaises (200), 58(5), 291-302.
STN search report: Panaiotova et al., Doklady Bolgarskoi Akademii Nauk, 1985, 38(5), 591-4.

Affiliated with

Also associated with

Rating

Derivatives of azaspiro compounds for the treatment of pain does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Derivatives of azaspiro compounds for the treatment of pain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of azaspiro compounds for the treatment of pain will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3894748